Home › Endometrial Cancer › Indiana › Fort Wayne
Endometrial Cancer clinical trials in Fort Wayne, IN
5 studies for Endometrial Cancer are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecruitingPhase 3
- Parkview Research Center ( Site 6008), Fort Wayne
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Fort Wayne
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
RecruitingPhase 3
- Parkview Research Center, Fort Wayne
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Parkview Research Center, Fort Wayne
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RecruitingPhase 2/3
- Parkview Research Center, Fort Wayne
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
- Oklahoma City, OK25 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Melanoma4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Triple-Negative Breast Cancer4 studies
- Colorectal Cancer4 studies
- Multiple Myeloma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.